FIELD: biotechnology.
SUBSTANCE: invention relates to a method of treating or preventing a disease or pathological condition associated with bone loss. Also disclosed is a method of treating or preventing a disease or pathological condition associated with decreased muscle function, as well as a method of treating or preventing cancer-related bone destruction.
EFFECT: invention is effective for treating osteoporosis, osteogenesis imperfecta, muscular atrophy, sarcopenia and cachexia.
32 cl, 6 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| REGULATION OF METABOLISM USING MIR-378 | 2011 |
|
RU2585491C2 |
| DOUBLE TARGETING OF NUCLEOTIDE SEQUENCES MIR-208 AND MIR 499 IN TREATING CARDIAC DISEASES | 2010 |
|
RU2515926C2 |
| NUETRALISING ANTIBODIES AGAINST GDF-8 AND THEIR APPLICATION | 2003 |
|
RU2360925C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING microRNA-100 AND USE THEREOF IN MODULATING GROWTH OF BLOOD VESSELS AND ENDOTHELIUM INFLAMMATION | 2010 |
|
RU2586531C2 |
| METHODS OF TREATING COLORECTAL CANCER | 2014 |
|
RU2674147C2 |
| USE OF MYOSTATIN ANTAGONISTS, COMBINATION CONTAINING THEM AND THEIR USE | 2016 |
|
RU2781401C2 |
| αvβ3 SELECTIVE POLYPEPTIDE, METHOD FOR PREPARING IT, POLYNUCLEOTIDE CODING IT, COMPOSITION CONTAINING SAID PEPTIDE, AND METHOD FOR TREATING AND PREVENTING | 2007 |
|
RU2477727C2 |
| ANTIBODIES TO HUMAN CSF-1R AND USE THEREOF | 2011 |
|
RU2617966C2 |
| METHODS OF TREATING POLYCYSTIC KIDNEY DISEASE | 2016 |
|
RU2742300C2 |
| NON-MOUSE ANTI-M-CSF-ANTIBODY (VERSIONS), PREPARATION AND USE THEREOF | 2005 |
|
RU2401277C2 |
